I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Palandri, F.
159
results:
Search for persons
X
Format
Online (159)
Mediatypes
Articles (Online) (32)
Bookchapter (Online) (2)
OpenAccess-fulltext (125)
Languages
english (155)
italian (1)
Sorted by: Relevance
Sorted by: Year
?
1
Ruxolitinib Adherence in Myelofibrosis and Polycythemia Ver..:
Palandri, F.
;
Auteri, G.
;
Abruzzese, E.
...
Annals of Hematology. 103 (2024) 6 - p. 1931-1940 , 2024
Link:
https://doi.org/10.1007/..
?
2
P1010: RUXOLITINIB IN MYELODEPLETIVE MYELOFIBROSIS: RESPONS..:
Palandri, F.
;
Bartoletti, D.
;
Breccia, M.
...
HemaSphere. 6 (2022) - p. 900-901 , 2022
Link:
https://doi.org/10.1097/..
?
3
P1030: MANIFEST-2, A GLOBAL, PHASE 3, RANDOMIZED, DOUBLE-BL..:
Harrison, C.
;
Rampal, R. K.
;
Gupta, V.
...
HemaSphere. 6 (2022) - p. 920-921 , 2022
Link:
https://doi.org/10.1097/..
?
4
P1068: RISK-ADJUSTED SAFETY ANALYSIS OF PACRITINIB IN PATIE..:
Vannucchi, A.
;
Pemmaraju, N.
;
Scott, B.
...
HemaSphere. 6 (2022) - p. 958-959 , 2022
Link:
https://doi.org/10.1097/..
?
5
P995: MYELOID NEOPLASMS-ASSOCIATED GENE VARIANTS IN 639 PAT..:
Mora, B.
;
Guglielmelli, P.
;
Kuykendall, A.
...
HemaSphere. 6 (2022) - p. 885-886 , 2022
Link:
https://doi.org/10.1097/..
?
6
Covid-19 in Philadelphia-negative myeloproliferative neopla..:
Breccia, M.
;
Piciocchi, A.
;
Messina, M.
...
Leukemia. 36 (2022) 10 - p. 2548-2550 , 2022
Link:
https://doi.org/10.1038/..
?
7
P1051: A PHASE 2 STUDY OF IMG-7289 (BOMEDEMSTAT) IN PATIENT..:
Gill, H.
;
Yacoub, A.
;
Pettit, K.
...
HemaSphere. 6 (2022) - p. 941-942 , 2022
Link:
https://doi.org/10.1097/..
?
8
P1033: A PHASE 2 STUDY OF THE LSD1 INHIBITOR IMG-7289 (BOME..:
Palandri, F.
;
Ross, D. M.
;
Cochrane, T.
...
HemaSphere. 6 (2022) - p. 923-924 , 2022
Link:
https://doi.org/10.1097/..
?
9
P1009: PREDICTORS OF HOSPITALIZATION AND SEVERE OUTCOMES IN..:
Barbui, T.
;
Carobbio, A.
;
Masciulli, A.
...
HemaSphere. 6 (2022) - p. 899-900 , 2022
Link:
https://doi.org/10.1097/..
?
10
P1011: PREDICTORS OF COVID-19 DISEASE AND SURVIVAL TO COVID..:
Palandri, F.
;
Bartoletti, D.
;
Elli, E. M.
...
HemaSphere. 6 (2022) - p. 901-902 , 2022
Link:
https://doi.org/10.1097/..
?
11
S198: BET INHIBITOR PELABRESIB (CPI-0610) COMBINED WITH RUX..:
Mascarenhas, J.
;
Kremyanskaya, M.
;
Patriarca, A.
...
HemaSphere. 6 (2022) - p. 99-100 , 2022
Link:
https://doi.org/10.1097/..
?
12
Tapering and discontinuation of thrombopoietin receptor ago..:
Zaja, F.
;
Carpenedo, M.
;
Baratè, C.
...
Blood Reviews. 41 (2020) - p. 100647 , 2020
Link:
https://doi.org/10.1016/..
?
13
Phase 2 study of gandotinib (LY2784544) in patients with my..:
Berdeja, J.
;
Palandri, F.
;
Baer, M.R.
...
Leukemia Research. 71 (2018) - p. 82-88 , 2018
Link:
https://doi.org/10.1016/..
?
14
A clinical-molecular prognostic model to predict survival i..:
Passamonti, F
;
Giorgino, T
;
Mora, B
...
Leukemia. 31 (2017) 12 - p. 2726-2731 , 2017
Link:
https://doi.org/10.1038/..
?
15
Driver mutations' effect in secondary myelofibrosis: an int..:
Passamonti, F
;
Mora, B
;
Giorgino, T
...
Leukemia. 31 (2016) 4 - p. 970-973 , 2016
Link:
https://doi.org/10.1038/..
1-15